Skip to content


Critical Care

Open Access

Thromboembolic risk factors and thromboprophylaxis in a medical–surgical ICU in Mexico

  • FJ Perez-Rada1,
  • JM Cerda-Arteaga1,
  • E Villanueva-Guzman1,
  • VM Sanchez-Nava1 and
  • E Fernandez-Rangel1
Critical Care200913(Suppl 1):P445

Published: 13 March 2009


Pulmonary EmbolismEnoxaparinVenous ThromboembolicThrombotic EventMechanical Device


Venous thromboembolic disease (VTD) is an important cause of morbimortality of critically ill patients, whom frequently have several VTD risk factors but lack the appropriate preventive measures. We conducted a study to identify the VTD risk factors, prevalence and use of prophylaxis in our ICU.


We conducted a prospective, observational study of all patients admitted to the adult ICU of our hospital in a 4-month period. We documented epidemiological data, VTD risk factors, and use of thromboprophylaxis. We used a risk scale that stratified patients in one of four levels of thromboembolic risk (low, intermediate, high, and very high) according to the number of VTD risk factors present. Daily clinical screenings for pulmonary or peripheral venous thromboembolism (VTE) were performed. Patients were contacted 30 days after discharge from the ICU to assess for any post-ICU VTE events.


Two hundred and eighteen consecutive patients were included (134 males) with an average age of 61 ± 18.6 years. The average length of stay at the ICU was 5.7 ± 12.9 days. The most frequent risk factors were age >60 years (83%), obesity (41%), smoking (33%), recent major surgical procedure (30%), and diabetes (22%). A total of 51.4% (112/218) of the patients had five or more VTD risk factors (very-high-risk category), while 34% (74/218) had three to four VTD risk factors (high-risk category). Less than 50% of the patients received any thromboprophylaxis. Most of those that had VTD prophylaxis used mechanical devices (96/218; 44%), followed by low molecular weight heparins such as enoxaparin (82/218; 38%). Twelve patients developed an identifiable thrombotic event: six male patients developed VTE while in the ICU; two of them developed massive pulmonary embolism and died. On follow-up assessment we contacted 183 patients and identified six that developed clinical data of a new, nonsevere VTE event after ICU discharge. All 12 patients who developed VTE had five or more VTD risk factors, locating them in the very-high-risk category.


Most of the patients admitted to our ICU had several risk factors that predisposed them to VTE events. In spite of that, less than one-half of our patients received VTD prophylaxis. VTE developed only in patients who had five or more risk factors. We suggest performing regular VTE assessments in this group of patients.

Authors’ Affiliations

Hospital San Jose Tec de Monterrey, Mexico


  1. Geerts WH, et al.: Chest. 2004, 126: 338S-400S. 10.1378/chest.126.3_suppl.338SView ArticleGoogle Scholar


© Perez-Rada et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.